Abstract
With the widespread use of radiological studies a greater number of hepatic lesions are identified. Although most of these lesions are benign, a small percentage can be malignant. Hence, a systematic approach and choosing the correct radiological imaging modality can help a physician manage these lesions without the need for exhaustive and time-consuming workup and may prevent a patient from undergoing unnecessary intervention. A number of factors should be considered in the evaluation of a hepatic lesion. These include the patient’s age, gender, medications, such as oral contraceptives or anabolic steroids, their travel history and any previous liver disease or cancers. A triple-phase CT or MRI, which includes a late arterial phase, a portal venous phase, and a delayed venous phase, can help to accurately diagnose a hepatic lesion more than 90 % of the time. Lesions seen in the background of chronic liver disease or cirrhosis should be considered hepatocellular carcinoma until proven otherwise.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reed SL. Amebiasis: An update. Clin Inf Dis. 1992;14:385–91.
Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology. 1984;86(6):1404.
Briux et al. Management of hepatocellular carcinoma: an Update, Hepatology, 2011; 53:1020–1022.
Holzapfel K, Breitwieser C, Prinz C, et al. Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA: preliminary experience and clinical applications [in German]. Radiologe. 2007;47:536–44.
Zizka J, Klzo L, Ferda J, et al. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol. 2007;62:186–91.
Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2008;18:457–67.
Zech CJ, Herrmann KA, Reiser MF, et al. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOBDTPA. Magn Reson Med Sci. 2007;6:43–52.
Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97–104.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rizvi, S. (2017). Incidental Hepatic Lesions. In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-30103-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30101-3
Online ISBN: 978-3-319-30103-7
eBook Packages: MedicineMedicine (R0)